November 5, 2021
Harnessing the power of biomarkers from discovery to late-stage clinical development and companion diagnostics (CDx)
You might also be interested by
Scientific Publications
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
July 18, 2022
Histopathology
More infoWeb News
CellCarta Launches Advanced AI-Powered Spatial Biology Data for Clinical Trials
March 1, 2022
Histopathology
More info